Barton Shane
Principal Accounting Officer
Barton Shane has filed 1 SEC Form 4 filing (10 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Barton Shane is listed as Principal Accounting Officer at BioAge Labs, Inc. Inside the rolling window, Barton Shane reported no open-market purchases and 2 open-market sales totaling $1.6M in BIOA. The largest disclosed transaction in the window is a sale of 42,350 BIOA shares on Jun 29, 2026, worth $1.1M.
Companies traded
Other insiders at BIOA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Barton Shane made?
Barton Shane has filed 1 SEC Form 4 filing (10 transaction rows) across 1 company since 2026.
Which companies does Barton Shane trade?
Barton Shane has filed SEC Form 4 disclosures for 1 company, including BIOA.
When was Barton Shane's most recent SEC Form 4 filing?
Barton Shane's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Barton Shane's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Barton Shane is listed as Principal Accounting Officer.
What is Barton Shane's total buy and sell value in the current window?
Inside the rolling retention window, Barton Shane bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Barton Shane's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 42,350 BIOA shares on 2026-06-29, worth $1.1M, per SEC Form 4 filings.